Health

Health
Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.
FDA panel narrowly backs COVID-19 pill from Merck
A panel of U.S. health advisers on Tuesday narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus.
Famed author Jodi Picoult novelizes the pandemic in new book 'Wish You Were Here'
Picoult's pandemic-inspired story focusing on a character stranded in the Galápagos Islands highlights how events can change us — and offer perspective.
As the Potter trial begins, how to process our reactions to disturbing subject matter
The trial of former Brooklyn Center police officer Kimberly Potter, who fatally shot Daunte Wright in April, has begun. Susan Beaulieu, an expert in mind-body healing, joined host Cathy Wurzer to share tips on how to stay in touch with our responses to disturbing subject matter.
Brazil and Japan report first cases of the omicron variant
Brazil and Japan joined the rapidly widening circle of countries to report cases of the omicron variant Tuesday, while new findings indicate the mutant coronavirus was already in Europe close to a week before South Africa sounded the alarm.
Fact focus: New omicron variant fuels old misinformation
A new coronavirus variant revived old conspiracy theories this week as widely shared social media posts falsely claimed the omicron variant was nothing but a cover-up for darker agendas.
Preliminary data about omicron suggests the variant became widespread across southern Africa in a very short period of time. Scientists say its many mutations may play a role in its transmissibility.